The Supreme Court has agreed to hear a case concerning the drug mifepristone, used for early-stage abortions.
The case involves a lower court ruling that sought to restrict the availability of the pill, prompting a legal challenge by the Christian legal group Alliance Defending Freedom.
“Every court so far has agreed that the FDA acted unlawfully in removing common-sense safeguards for women and authorizing dangerous mail-order abortions,” ADF lawyer Erin Hawley stated. (Trending: New Movie Obamas Helped Make Raises Eyebrows: ‘Don’t Trust White People’)
“We urge the Supreme Court to do the same.”
“The FDA has harmed the health of women and undermined the rule of law by illegally removing every meaningful safeguard from the chemical abortion drug regimen. Like any federal agency, the FDA must rationally explain its decisions,” Hawley added.
“Yet its removal of common-sense safeguards — like a doctor’s visit before women are prescribed chemical abortion drugs — does not reflect scientific judgment but rather a politically driven decision to push a dangerous drug regimen.”
The FDA’s decision to expand access to the drug, including by mail, has sparked controversy, with the White House defending the FDA’s approval and regulation of the drug.
“This Administration will continue to stand by FDA’s independent approval and regulation of mifepristone as safe and effective,” Jean-Pierre said.
“No woman should be unable to access the health care that she needs. This should not happen in America, period.”
“The FDA actions at issue were well supported by extensive safety and effectiveness data from clinical trials and decades worth of real-world experience in millions of patients,” the company stated.
The case is expected to be a significant abortion case, with oral arguments set to begin early next year and a decision expected by the end of June.
Most Popular:
Hunter Biden’s Own Memoir Is Coming Back To Haunt Him In Criminal Trial
LeBron James Shares Gun Advice For Americans
Top Democrat Loses In Historic Landslide
